General Information of the Protein
Protein ID
PT00866
Protein Name
Stromelysin-1
Secondarily
Protein Name
Matrix metalloproteinase-3
Transin-1
Gene Name
MMP3
Secondarily
Gene Name
STMY1
Sequence
MKSLPILLLLCVAVCSAYPLDGAARGEDTSMNLVQKYLENYYDLKKDVKQFVRRKDSGPVVKKIREMQKFLGLEVTGKLDSDTLEVMRKPRCGVPDVGHFRTFPGIPKWRKTHLTYRIVNYTPDLPKDAVDSAVEKALKVWEEVTPLTFSRLYEGEADIMISFAVREHGDFYPFDGPGNVLAHAYAPGPGINGDAHFDDDEQWTKDTTGTNLFLVAAHEIGHSLGLFHSANTEALMYPLYHSLTDLTRFRLSQDDINGIQSLYGPPPDSPETPLVPTEPVPPEPGTPANCDPALSFDAVSTLRGEILIFKDRHFWRKSLRKLEPELHLISSFWPSLPSGVDAAYEVTSKDLVFIFKGNQFWAIRGNEVRAGYPRGIHTLGFPPTVRKIDAAISDKEKNKTYFFVEDKYWRFDEKRNSMEPGFPKQIAEDFPGIDSKIDAVFEEFGFFYFFTGSSQLEFDPNAKKVTHTLKSNSWLNC
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Protease
>
Metallo protease
>
Metallo protease MAM clan
>
Metallo protease M10A subfamily
Function
Metalloproteinase with a rather broad substrate specificity that can degrade fibronectin, laminin, gelatins of type I, III, IV, and V; collagens III, IV, X, and IX, and cartilage proteoglycans. Activates different molecules including growth factors, plasminogen or other matrix metalloproteinases such as MMP9 (PubMed:11029580, PubMed:1371271). Once released into the extracellular matrix (ECM), the inactive pro-enzyme is activated by the plasmin cascade signaling pathway (PubMed:2383557). Acts also intracellularly (PubMed:22265821). For example, in dopaminergic neurons, gets activated by the serine protease HTRA2 upon stress and plays a pivotal role in DA neuronal degeneration by mediating microglial activation and alpha-synuclein/SNCA cleavage (PubMed:21330369). In addition, plays a role in immune response and possesses antiviral activity against various viruses such as vesicular stomatitis virus, influenza A virus (H1N1) and human herpes virus 1 (PubMed:35940311). Mechanistically, translocates from the cytoplasm into the cell nucleus upon virus infection to influence NF-kappa-B activities (PubMed:35940311).
    Show/Hide
Uniprot ID
Primary ID:
P08254

Secondarily ID:
B2R8B8
Q3B7S0
Q6GRF8
    Show/Hide
Ensembl ID
ENSG00000149968
HGNC ID
HGNC:7173
Subcellular Location
Secreted
Extracellular space
Extracellular matrix
Nucleus
Cytoplasm
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000011 , CHO
Compound ID Compound Name Compound Formula
CP0069428
US9206139, 1
   Show/Hide
C18H20F3N3O3
 1
1
IC50 = 2845 nM
   TI
   LI
   LO
   TS
CP0069431
US9206139, 5
   Show/Hide
C19H22F3N3O3
 1
1
IC50 = 13165 nM
   TI
   LI
   LO
   TS
CP0199497
US9206139, 2
   Show/Hide
C19H22F3N3O3
 1
1
IC50 = 15342 nM
   TI
   LI
   LO
   TS
CP0118960
US9206139, 3
   Show/Hide
C20H22F3N3O3
 1
1
IC50 = 99710 nM
   TI
   LI
   LO
   TS
CP0069429
US9206139, 4
   Show/Hide
C20H24F3N3O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0048641
(2S,3R)-N(4)-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N(1),2-dihydroxy-3-(2-methylpropyl)butanediamide
   Show/Hide
C15H29N3O5
 8
1 IC50 = 4.4 nM
2 IC50 = 14 nM
3 IC50 = 25 nM
4 IC50 = 200 nM
5 IC50 = 10000 nM
6 Ki = 2.4 nM
7 Ki = 8.9 nM
8 Ki = 84 nM
CP0069428
US9206139, 1
   Show/Hide
C18H20F3N3O3
 1
1 IC50 = 2800 nM
CP0069431
US9206139, 5
   Show/Hide
C19H22F3N3O3
 1
1 IC50 = 13000 nM
CP0199497
US9206139, 2
   Show/Hide
C19H22F3N3O3
 1
1 IC50 = 15000 nM
CP0069429
US9206139, 4
   Show/Hide
C20H24F3N3O3
 1
1 IC50 > 100000 nM
CP0118960
US9206139, 3
   Show/Hide
C20H22F3N3O3
 1
1 IC50 > 100000 nM
Clinical Information about the Protein
Target 1 ( Matrix metalloproteinase-3 (MMP-3) )
Target Type Patented-recorded Target
Disease 5 Target-related Diseases  5
1 Corneal ulcer [ICD-11: 9A76]
2 Hepatitis C virus infection [ICD-11: 1E51.1]
3 Idiopathic pulmonary fibrosis [ICD-11: CB03.4]
4 Multiple sclerosis [ICD-11: 8A40]
5 Rheumatoid arthritis [ICD-11: FA20]
Discontinued Drug(s) 4 Discontinued Drugs  4
1 GM6001 Discontinued in Phase 2
Corneal ulcer
2 RS-130830 Discontinued in Phase 2
Hepatitis C virus infection
3 BB-1101 Terminated
Multiple sclerosis
4 RO-319790 Terminated
Rheumatoid arthritis
Preclinical Drug(s) 1 Preclinical Drug  1
1 Batimastat Preclinical
Idiopathic pulmonary fibrosis